Diligence memo · auto-generated · as of July 2, 2026
Triple Endoscopy, Inc.
Triple Endoscopy, Inc. looks fair against its niche peers and is quiet on financing cadence.
Businessfiled
Triple Endoscopy, Inc. operates in Other Health Care, based in CENTENNIAL.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Triple Endoscopy, Inc. has raised $4.7M in disclosed capital across 3 recorded rounds, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $2.3M on 2024-08-02.
Most recent recorded round closed around 2024-08-02.
Valuation (modeled)modeled
Provath models Triple Endoscopy, Inc. at approximately $9.6M (range $1.9M–$25M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 0.80× the median modeled value of Seed Other Health Care companies in 2022–2024 (244 peers) — value vs value, same stage and era. Within the normal band (80% of peer median) for its niche.
Financing rhythm & timingmixed
Historic cadence: a new round about every 39 months.
Last raise 23 mo ago; this sector typically re-raises about every 14 months.
Slightly overdue versus sector cadence.
The last round stepped up 1.2× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 63% of Other Health Care peers (5377 compared).
Modeled value ranks above 34% of those peers.
Closest niche peers: Elmntri LLC, Atreo, Inc., descendantsDNA, Inc., Westover Project Investor LLC, Dentulu Inc.
Peoplefiled
12 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.